Ingalls & Snyder LLC’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-16,500
| Closed | -$19K | – | 444 |
|
|
2019
Q2 | $19K | Hold |
16,500
| – | – | ﹤0.01% | 421 |
|
|
2019
Q1 | $19K | Hold |
16,500
| – | – | ﹤0.01% | 411 |
|
|
2018
Q4 | $17K | Sell |
16,500
-10,000
| -38% | -$10K | ﹤0.01% | 407 |
|
|
2018
Q3 | $31K | Hold |
26,500
| – | – | ﹤0.01% | 442 |
|
|
2018
Q2 | $44K | Hold |
26,500
| – | – | ﹤0.01% | 401 |
|
|
2018
Q1 | $35K | Buy |
26,500
+9,500
| +56% | +$13.5K | ﹤0.01% | 395 |
|
|
2017
Q4 | $23K | Buy |
17,000
+7,000
| +70% | +$8.43K | ﹤0.01% | 392 |
|
|
2017
Q3 | $10K | Buy |
+10,000
| New | +$9.42K | ﹤0.01% | 361 |
|
|
2016
Q3 | – | Sell |
-10,000
| Closed | -$15K | – | 434 |
|
|
2016
Q2 | $15K | Hold |
10,000
| – | – | ﹤0.01% | 422 |
|
|
2016
Q1 | $25K | Sell |
10,000
-10,000
| -50% | -$22.5K | ﹤0.01% | 355 |
|
|
2015
Q4 | $46K | Hold |
20,000
| – | – | ﹤0.01% | 363 |
|
|
2015
Q3 | $37K | Hold |
20,000
| – | – | ﹤0.01% | 357 |
|
|
2015
Q2 | $39K | Hold |
20,000
| – | – | ﹤0.01% | 369 |
|
|
2015
Q1 | $32K | Buy |
+20,000
| New | +$34.1K | ﹤0.01% | 375 |
|
Ingalls & Snyder LLC's IMI Position: Q3 2019 in Review
Ingalls & Snyder LLC sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 16,500 shares — an estimated $19K sold.
Ingalls & Snyder LLC first reported a position in IMI in Q1 2015 and held it in 14 quarters. The position peaked at $46K in Q4 2015. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.
- Ingalls & Snyder LLC reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
- Ingalls & Snyder LLC sold 16,500 Intermolecular, Inc. shares in Q3 2019, an estimated $19K.
- Ingalls & Snyder LLC first reported a position in Intermolecular, Inc. in Q1 2015 and held it in 14 quarters.
- Ingalls & Snyder LLC's Intermolecular, Inc. position peaked at $46K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.
Based on Ingalls & Snyder LLC's 13F filing for Q3 2019, filed 16 Oct 2019.